Find Federal Grants
National Institute of Food and Agriculture · USDA-NIFA-BRAP-010309
Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
Food and Drug Administration · FOR-FD-24-015
Food and Drug Administration · FOR-FD-24-014
Food and Drug Administration · FOR-FD-24-013
Food and Drug Administration · FOR-FD-24-012
National Institute of Food and Agriculture · USDA-NIFA-FINI-010373
Foreign Agricultural Service · USDA-FAS-RAPP-2024
National Institute of Food and Agriculture · USDA-NIFA-OP-010333
Methyl Bromide Transition Program
National Institute of Food and Agriculture · USDA-NIFA-ICGP-010334
Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)
Food and Drug Administration · FOR-FD-24-010
National Institute of Food and Agriculture · USDA-NIFA-ICGP-010314
Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed
Food and Drug Administration · FOR-FD-24-009
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
Food and Drug Administration · FOR-FD-24-008
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
Food and Drug Administration · FOR-FD-24-007
Integrated Research, Education, and Extension Competitive Grants Program – Organic Transitions
National Institute of Food and Agriculture · USDA-NIFA-ICGP-010290
Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed
Food and Drug Administration · FOR-FD-24-006
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
Food and Drug Administration · FOR-FD-24-005
Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)
Food and Drug Administration · FOR-FD-24-004
Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed
Food and Drug Administration · FOR-FD-24-003
National Institute of Food and Agriculture · USDA-NIFA-CPPM-010315